Logo

ADUS

Addus HomeCare Corporation

ADUS

Addus HomeCare Corporation • NASDAQ
$120.20 ▼ -0.60% (-0.72)
Market Cap $2.22 B
52w High $136.72
52w Low $88.96
Dividend Yield 0%
P/E 25.79
Volume 106.50K
Outstanding Shares 18.48M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $362.301M ▲ $83.778M ▲ $22.848M ▲ 6.306% ▼ $1.22 $37.345M ▼
Q2-2025 $349.443M ▲ $80.99M ▲ $22.052M ▲ 6.311% ▲ $1.22 ▲ $37.383M ▲
Q1-2025 $337.708M ▲ $77.163M ▲ $21.228M ▲ 6.286% ▼ $1.18 ▲ $34.959M ▲
Q4-2024 $297.144M ▲ $74.57M ▲ $19.526M ▼ 6.571% ▼ $1.08 ▼ $31.715M ▲
Q3-2024 $289.787M $66.251M $20.163M 6.958% $1.13 $31.307M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $101.918M ▲ $1.423B ▲ $372.964M ▼ $1.05B ▲
Q2-2025 $91.176M ▼ $1.409B ▲ $387.077M ▼ $1.022B ▲
Q1-2025 $96.954M ▼ $1.408B ▼ $412.201M ▼ $995.383M ▲
Q4-2024 $98.911M ▼ $1.413B ▲ $442.142M ▲ $970.492M ▲
Q3-2024 $222.852M $1.153B $205.267M $947.634M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $22.848M ▲ $51.288M ▲ $-22.761M ▼ $-17.785M ▲ $10.742M ▲ $49.368M ▲
Q2-2025 $-21.228M ▼ $22.529M ▲ $1.695M ▲ $-30.002M ▼ $-5.778M ▼ $24.412M ▲
Q1-2025 $21.228M ▲ $18.949M ▲ $-1.378M ▲ $-19.528M ▼ $-1.957M ▲ $17.066M ▲
Q4-2024 $19.526M ▼ $10.418M ▼ $-354.486M ▼ $220.127M ▲ $-123.941M ▼ $8.721M ▼
Q3-2024 $20.163M $48.525M $-1.922M $2.944M $49.547M $46.593M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Home Health
Home Health
 $40.00M ▲$20.00M ▼$20.00M ▲$20.00M ▲
Hospice
Hospice
 $120.00M ▲$60.00M ▼$60.00M ▲$70.00M ▲
Personal Care
Personal Care
 $430.00M ▲$260.00M ▼$270.00M ▲$280.00M ▲

Five-Year Company Overview

Income Statement

Income Statement Addus shows a clear pattern of steady growth. Revenue has risen each year, and profits have generally grown faster than sales, which suggests improving efficiency and solid cost control. Operating and net margins have been edging higher, helped by scale and a shift toward somewhat higher‑margin services like home health and hospice. Earnings per share have climbed meaningfully over the five‑year period, indicating that the business is not just getting bigger, but also more profitable on a per‑share basis. The main watchpoints are ongoing wage pressure in home care and reimbursement rates from government payers, which can both squeeze margins if not managed carefully.

Balance Sheet

Balance Sheet The balance sheet looks conservative and steadily stronger over time. Total assets and shareholder equity have grown, reflecting retained earnings and disciplined expansion. Debt exists but appears moderate relative to the size of the business and equity base, and leverage has not spiked in a worrying way. Cash balances move around year to year, but the company generally maintains a reasonable liquidity cushion. Overall, Addus appears to fund growth with a healthy mix of internal cash generation and manageable borrowing, rather than relying heavily on debt.

Cash Flow

Cash Flow Cash generation is a notable strength. Operating cash flow has been consistently positive and has broadly kept pace with profit growth, which supports the quality of earnings. Free cash flow is strong and relatively stable because the business does not require heavy capital spending; its model is people‑ and technology‑intensive rather than asset‑intensive. This leaves room to fund acquisitions, invest in systems, and reduce debt when management chooses, without depending on capital markets. Any sudden change in reimbursement timing or working capital needs would be worth watching, but recent history looks solid.

Competitive Edge

Competitive Edge Addus is positioning itself as an integrated home‑based care platform rather than a simple personal care provider. Its “continuum of care” model—personal care, home health, and hospice, often in the same markets—creates stickier relationships with patients and payers. The integrated electronic medical record system helps coordinate care and can be attractive to managed care organizations that want bundled, value‑based solutions. A broad payer mix across Medicaid, Medicare, and other sources provides diversification, though it also ties the business closely to public reimbursement policy. Competition in home care is intense and labor‑driven, but Addus’s scale, technology, and multi‑service offering give it a meaningful edge versus smaller, single‑line rivals.

Innovation and R&D

Innovation and R&D Innovation at Addus is centered on care models and technology rather than traditional lab research. The partnership with Homecare Homebase to build a unified electronic medical record across all service lines is a key asset, enabling smoother handoffs between personal care, home health, and hospice. The “bridging” program, which uses this system to identify when clients should transition to hospice, has already boosted hospice volumes in test markets and improves the patient experience. Addus is also leaning into virtual tools to connect caregivers, patients, and families, and is exploring physician house calls to deepen its in‑home medical presence. Ongoing technology upgrades and thoughtful acquisitions are likely to remain the main drivers of innovation.

Summary

Addus HomeCare combines steady financial performance with a clear strategic identity in home‑based care. The company has delivered consistent revenue and earnings growth, improved profitability, and maintains a solid, conservative balance sheet with reliable free cash flow. Its competitive edge comes from an integrated continuum of services, a growing technology backbone, and a diversified payer mix, all set against a long‑term tailwind of an aging population and preference for care at home. Key risks to monitor include labor availability and wage inflation, changes in government reimbursement, and execution on acquisitions and technology rollouts. Overall, Addus appears to be evolving from a traditional home care operator into a more sophisticated, tech‑enabled care platform, with financials that so far support that transition.

NEWS

November 5, 2025 · 11:00 AM UTC

Addus HomeCare to Participate in Upcoming Investor Conferences in November

Read more

November 3, 2025 · 4:05 PM UTC

Addus HomeCare Announces Third Quarter 2025 Financial Results

Read more

October 20, 2025 · 11:00 AM UTC

Addus HomeCare Announces Third Quarter 2025 Earnings Release and Conference Call

Read more

September 23, 2025 · 11:00 AM UTC

Addus HomeCare to Participate in the Jefferies 2025 Healthcare Services Conference

Read more